Status:
COMPLETED
Patient Specific Induced Pluripotency Stem Cells (PSiPS)
Lead Sponsor:
Royan Institute
Conditions:
Hepatic Disorders
Eye Disorders
Eligibility:
All Genders
12-80 years
Brief Summary
Induced pluripotent stem cells (iPSCs) are adult cells that have been genetically reprogrammed to an embryonic stem cell-like state by being forced to express genes and factors important for maintaini...
Detailed Description
iPS cells are typically derived by transfection of certain stem cell-associated genes into non-pluripotent cells, such as adult fibroblasts. Transfection is typically achieved through viral vectors, s...
Eligibility Criteria
Inclusion
- Donors suffering from different (specified) metabolic disorders
- Donors suffering from different (specified) eye disorders which resulted to blindness
- Special blood group: O Bombay
Exclusion
- None
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2010
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00953693
Start Date
April 1 2009
End Date
July 1 2010
Last Update
December 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royan Institute
Tehran, Tehran Province, Iran